BMS 833923

BMS 833923 Basic information
Product Name:BMS 833923
Synonyms:BMS 833923;XL 139;XL139;XL-139;BMS-833923 (XL-139);N-[2-Methyl-5-[(methylamino)methyl]phenyl]-4-[(4-phenylquinazolin-2-yl)amino]benzamide;Benzamide, N-[2-methyl-5-[(methylamino)methyl]phenyl]-4-[(4-phenyl-2-quinazolinyl)amino]-;BMS 833923 N-[2-Methyl-5-[(methylamino)methyl]phenyl]-4-[(4-phenylquinazolin-2-yl)amino]benzamide
CAS:1059734-66-5
MF:C30H27N5O
MW:473.57
EINECS:
Product Categories:Inhibitors
Mol File:1059734-66-5.mol
BMS 833923 Structure
BMS 833923 Chemical Properties
density 1.252±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility ≥47.4 mg/mL in DMSO; insoluble in H2O; ≥5.14 mg/mL in EtOH with gentle warming and ultrasonic
form solid
pka13.42±0.70(Predicted)
Safety Information
MSDS Information
BMS 833923 Usage And Synthesis
DescriptionSmoothened (Smo) is a cell surface receptor that, with Patched, mediates sonic hedgehog (Shh) signaling to regulate gene expression through the Gli transcription factors. BMS 833923 is an orally bioavailable inhibitor of Smo. It blocks binding of BODIPY cyclopamine (IC50 = 21 nM) and inhibits Gli activation in cell lines that express wild-type Smo or activated mutant forms of Smo (IC50s = 6-35 nM). BMS 833923 robustly inhibits Shh pathway activity and prevents tumor growth in medulloblastoma and pancreatic carcinoma xenograft models.
UsesBMS 833923 is an antagonist of smoothened, a key hedgehog (Hh) pathway regulator.
BMS 833923 Preparation Products And Raw materials
XL147 Taladegib (LY2940680) Mutant IDH1 inhibitor CNX-1351 MS436 Sunitinib Malate XL019 Vismodegib (GDC-0449) LDE225 (NVP-LDE225,Erismodegib) BIX 02189 TG101209 Cabozantinib CCT 137690 pilaralisib PFK-015 LY 303511 (hydrochloride) Glasdegib TENOVIN-1

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.